Cyana Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Cyana Therapeutics General Information
Description
Developer of immuno-oncology therapies designed to treat solid tumors. The company develops small-molecule ENPP1 inhibitors with extended drug-target residence time that block ENPP1, which is frequently overexpressed in liver, pancreatic, breast, and lung cancers, enabling oncologists to target tumor immune evasion pathways with precision immunotherapies.
Contact Information
Website
www.cyanatx.comCorporate Office
- 929 Alton Road
- Suite 500
- Miami Beach, FL 33139
- United States
Corporate Office
- 929 Alton Road
- Suite 500
- Miami Beach, FL 33139
- United States
Cyana Therapeutics Timeline
Cyana Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jul-2026 | Completed | Pre-Clinical Trials | |||
| 1. Angel (individual) | 22-Dec-2025 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cyana Therapeutics Patents
Cyana Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240390400-A1 | Enpp1 inhibitors as inhibitors of metastasis | Pending | 29-Oct-2021 | ||
| US-20240374724-A1 | Enpp1 inhibitors and immune cells expressing chimeric antigen receptors | Pending | 03-Sep-2021 | ||
| US-20230190927-A1 | Enpp1 inhibitors and methods of modulating immune response | Pending | 04-May-2020 | A61K39/39 |
Cyana Therapeutics Signals
Cyana Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Transhuman Capital | Venture Capital | Minority | ||
| Collage Venture Partners | Venture Capital | Minority |
Cyana Therapeutics FAQs
-
When was Cyana Therapeutics founded?
Cyana Therapeutics was founded in 2025.
-
Where is Cyana Therapeutics headquartered?
Cyana Therapeutics is headquartered in Miami Beach, FL.
-
What is the size of Cyana Therapeutics?
Cyana Therapeutics has 3 total employees.
-
What industry is Cyana Therapeutics in?
Cyana Therapeutics’s primary industry is Drug Discovery.
-
Is Cyana Therapeutics a private or public company?
Cyana Therapeutics is a Private company.
-
What is Cyana Therapeutics’s current revenue?
The current revenue for Cyana Therapeutics is .
-
How much funding has Cyana Therapeutics raised over time?
Cyana Therapeutics has raised $151K.
-
Who are Cyana Therapeutics’s investors?
Transhuman Capital and Collage Venture Partners have invested in Cyana Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process